Novanta Acquires Riverpoint Medical for $1.45 Billion
Novanta has announced its acquisition of Riverpoint Medical in a deal valued at $1.45 billion. The company also raised $300 million privately to support the buyout.
Results for "Novanta"
18 stories found
Novanta (NOVT) Releases Q1 2026 Earnings Transcript
The transcript for Novanta's first quarter 2026 earnings call has been made available.
Khomeini: the ayatollah who defies the Shah's power
Nel giorno del novantaseiesimo compleanno, esce il libro che raccoglie i ritratti di donne e uomini incontrati dal giornalista nel corso della sua lunga carriera, protagonisti di episodi chiave dalla…
Is Novanta Stock a Buy or Sell After Its CEO Dumped 7,500 Shares Worth $1.1 Million?
Novanta's CEO sold 7,500 shares valued at $1.1 million, prompting market speculation on whether the stock is currently a buy or sell.
Novanta Targets Growth and Acquisition Capacity for 2026
Novanta has outlined its financial strategy, targeting 4%-6% organic growth for 2026 and announcing a $1.5 billion acquisition capacity, supported by record bookings and new product launches.
Novanta Q4 2025 Earnings Preview
An article provides a preview of Novanta's fourth-quarter 2025 earnings, outlining expectations for the company's performance.
Multiple Companies Announce Quarterly Earnings and Dividends
Several companies, including AVITA Medical, Xos, and Gambling.com, have released their latest quarterly earnings reports, with some beating and others missing analyst expectations. Additionally, JBT Marel and Kimberly-Clark declared quarterly dividends, while analysts offered insights on various healthcare companies.
Diverse Companies Announce Q1/Q2 2026 Earnings Previews and Results
Multiple companies, including Atour Lifestyle Holdings and National Vision Holdings, are either previewing their Q1 and Q2 2026 financial results or have already reported their GAAP EPS and revenue. This cluster covers a range of corporate earnings updates for the specified quarters.
Shimon Peres: the little-loved leader and the rival Netanyahu
Nel giorno del novantaseiesimo compleanno, esce il libro che raccoglie i ritratti di donne e uomini incontrati dal giornalista nel corso della sua lunga carriera, protagonisti di episodi chiave dalla…
Novanta Reports Q4 Earnings Call Highlights
Novanta has shared key highlights from its fourth-quarter earnings call, providing an update on its financial results and business operations.
Novanta (NOVT) Reports Q4 2025 Earnings
Novanta (NOVT) held its Q4 2025 earnings call, providing a transcript of the discussion regarding its financial performance and future projections.
Novanta Reports Strong Earnings Growth in Q4
Novanta (NOVT) experienced strong earnings growth in the fourth quarter, contributing to positive financial results.
Multiple Companies Update 2026 Revenue Forecasts
Several companies, including TriSalus, Velo3D, Neuropace, OptimizeRx, Arteris, and Novanta, have released or updated their financial forecasts. These updates primarily detail their projected revenue outlooks for 2026, with some also providing Q2 estimates or other financial targets.
Novanta Inc. Reports Q1 2026 Earnings
Novanta Inc. released its summary for the first quarter 2026 earnings call, detailing financial performance and key business updates for the period.
Novanta Stock Has Underperformed This Past Year, but One Investor Just Made a $36 Million Bet on Shares
Despite Novanta stock underperforming over the past year, one investor has made a substantial $36 million bet on its shares.
Novanta Inc. Q4 2025 Earnings Call Summary
Novanta beats top-line and bottom-line estimates; introduces Q1 and FY26 outlook
Novanta reported better-than-expected top-line and bottom-line results for the fourth quarter and introduced its outlook for Q1 and fiscal year 2026.
Investor Bets $45 Million on Novanta Stock Despite Flat Performance
Despite Novanta stock remaining relatively flat over the past year, one investor has made a substantial $45 million bet on its shares.